Enlivex Therapeutics (Israel) Technical Analysis
| ENLV Stock | ILA 415.10 4.10 0.98% |
As of the 29th of November, Enlivex Therapeutics shows the Mean Deviation of 2.96, standard deviation of 4.21, and Variance of 17.69. Enlivex Therapeutics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Enlivex Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Enlivex, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EnlivexEnlivex |
Enlivex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Enlivex Therapeutics Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Enlivex Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Enlivex Therapeutics Trend Analysis
Use this graph to draw trend lines for Enlivex Therapeutics. You can use it to identify possible trend reversals for Enlivex Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Enlivex Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Enlivex Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Enlivex Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.73 , which may suggest that Enlivex Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 20024.84, which is the sum of squared deviations for the predicted Enlivex Therapeutics price change compared to its average price change.About Enlivex Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Enlivex Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Enlivex Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Enlivex Therapeutics price pattern first instead of the macroeconomic environment surrounding Enlivex Therapeutics. By analyzing Enlivex Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Enlivex Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Enlivex Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Enlivex Therapeutics November 29, 2024 Technical Indicators
Most technical analysis of Enlivex help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Enlivex from various momentum indicators to cycle indicators. When you analyze Enlivex charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 4.81 | |||
| Mean Deviation | 2.96 | |||
| Coefficient Of Variation | (1,788) | |||
| Standard Deviation | 4.21 | |||
| Variance | 17.69 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.88) | |||
| Treynor Ratio | 4.8 | |||
| Maximum Drawdown | 25.31 | |||
| Value At Risk | (7.18) | |||
| Potential Upside | 6.94 | |||
| Skewness | 1.25 | |||
| Kurtosis | 3.91 |
Complementary Tools for Enlivex Stock analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |